Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
Public ClinicalTrials.gov record NCT05301335. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder
Study identification
- NCT ID
- NCT05301335
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- SpineX Inc.
- Industry
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Interventions
- SCONE Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 24, 2022
- Primary completion
- Apr 30, 2024
- Completion
- Apr 30, 2024
- Last update posted
- Feb 16, 2025
2022 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rancho Research Institute | Downey | California | 90242 | — |
| UC San Diego Health Systems | San Diego | California | 92093 | — |
| Craig Hospital | Denver | Colorado | 80113 | — |
| Medstar National Rehab | Washington D.C. | District of Columbia | 20010 | — |
| University of Miami, Desai Sehti Urology Institute | Miami | Florida | 33136 | — |
| Shepherd Centre | Atlanta | Georgia | 30309 | — |
| Spaulding Rehabilitation Hospital Cambridge | Cambridge | Massachusetts | 02138 | — |
| Mayo Clinic, St. Mary's Campus | Rochester | Minnesota | 55902 | — |
| Columbia University Irving Medical Centre | New York | New York | 10032 | — |
| Atrium Health | Charlotte | North Carolina | 28208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05301335, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05301335 live on ClinicalTrials.gov.